Aquatic Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Aquatic Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-40,342	Closed	-$616K	–	1402
2025 Q3	$616K	Buy	40,342 +31,609	+362%	+$411K	0.01%	816
2025 Q2	$77.3K	Sell	8,733 -17,120	-66%	-$150K	﹤0.01%	1114
2025 Q1	$202K	Buy	+25,853	New	+$217K	0.01%	929
2022 Q3	–	Sell	-26,600	Closed	-$65K	–	1174
2022 Q2	$65K	Buy	26,600 +26,000	+4,333%	+$107K	0.02%	589
2022 Q1	$4K	Sell	600 -800	-57%	-$5.5K	0.01%	852
2021 Q4	$11K	Buy	+1,400	New	+$12.8K	0.02%	760

Other funds holding AVDL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's AVDL Position: Q4 2025 in Review

Aquatic Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 40,342 shares — an estimated $616K sold.

Aquatic Capital Management first reported a position in AVDL in Q4 2021 and held it in 6 quarters. The position peaked at $616K in Q3 2025. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

Aquatic Capital Management reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Aquatic Capital Management sold 40,342 Avadel Pharmaceuticals shares in Q4 2025, an estimated $616K.
Aquatic Capital Management first reported a position in Avadel Pharmaceuticals in Q4 2021 and held it in 6 quarters.
Aquatic Capital Management's Avadel Pharmaceuticals position peaked at $616K in Q3 2025.
207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.